Article metrics

Download PDFPDF
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

 

Online download statistics by month:

Online download statistics by month: October 2021 to April 2022

AbstractFullPdf
Oct 20211661168
Nov 2021106113
Dec 202139723
Jan 202231763
Feb 202222142
Mar 202226100
Apr 202226900
Total41872919